North Run Capital Lp adds McKesson Corporation (MCK) to its portfolio

McKesson Corporation (MCK) : North Run Capital Lp added new position in McKesson Corporation during the most recent quarter end. The investment management firm now holds 300,000 shares of McKesson Corporation which is valued at $49.8 Million , the company said in a statement filed on May 13, 2016 with the SEC.McKesson Corporation makes up approximately 6.77% of North Run Capital Lp’s portfolio.

Other Hedge Funds, Including , Fiduciary Group boosted its stake in MCK in the latest quarter, The investment management firm added 1,509 additional shares and now holds a total of 6,417 shares of McKesson Corporation which is valued at $1.1 Million. McKesson Corporation makes up approx 0.31% of Fiduciary Group’s portfolio.Bessemer Group Inc reduced its stake in MCK by selling 63,049 shares or 15.55% in the most recent quarter. The Hedge Fund company now holds 342,426 shares of MCK which is valued at $56.8 Million. McKesson Corporation makes up approx 0.33% of Bessemer Group Inc’s portfolio.Great Lakes Advisors boosted its stake in MCK in the latest quarter, The investment management firm added 2,868 additional shares and now holds a total of 11,282 shares of McKesson Corporation which is valued at $1.9 Million. McKesson Corporation makes up approx 0.05% of Great Lakes Advisors’s portfolio.Alps Advisors Inc boosted its stake in MCK in the latest quarter, The investment management firm added 382 additional shares and now holds a total of 2,969 shares of McKesson Corporation which is valued at $492,646.

McKesson Corporation opened for trading at $182.94 and hit $185.5811 on the upside on Wednesday, eventually ending the session at $182.92, with a gain of 0.08% or 0.15 points. The heightened volatility saw the trading volume jump to 21,16,091 shares. Company has a market cap of $41,161 M.

On the company’s financial health, McKesson Corporation reported $2.44 EPS for the quarter, missing the analyst consensus estimate by $ -0.70 based on the information available during the earnings call on May 4, 2016. Analyst had a consensus of $3.14. The company had revenue of $46678.00 million for the quarter, compared to analysts expectations of $46810.61 million. The company’s revenue was up 3.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.94 EPS.

Many Wall Street Analysts have commented on McKesson Corporation. McKesson Corporation was Downgraded by Avondale to ” Mkt Perform” on May 5, 2016. McKesson Corporation was Downgraded by Standpoint Research to ” Hold” on Apr 26, 2016. Avondale Initiated McKesson Corporation on Apr 19, 2016 to “Mkt Outperform”, Price Target of the shares are set at $203.

McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals medical supplies and healthcare information technology. The Company operates through two business segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers and practice management technology clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical patient care financial supply chain and strategic management software solutions as well as connectivity outsourcing and other services including remote hosting and managed services to healthcare organizations.

Leave a Reply

McKesson Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on McKesson Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.